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• Infectious bronchopneumonia:
 Major economical impact in cattle 
production systems worldwide
 Bacterial pathogens: 
 Leading cause antimicrobial use 
in calves
 Pressure intensive antimicrobial 
consumption food producing 
animals
Introduction
Pasteurella multocida Histophilus somni
Mannheimia haemolytica Mycoplasma bovis




 1st choice products
 Certain classes: identification and 
susceptibility test requested
Introduction




• Genus within Pasteurellaceae
• Chickens: 
 opportunistic pathogen upper respiratory tract, 
lower genital tract
 salpingitis and peritonitis:    egg production,     
mortality
• Humans: 




Describe a clinical outbreak of infectious 
bronchopneumonia in beef calves associated 
with multiresistant Gallibacterium anatis 
strains
Case report
• 6 different beef herds suffering from infectious 
bronchopneumonia (2017-2018)
• 9 calves: 
Aged 22 days-4 months
5 calves presented at 2 different farms (farm 1: 4; farm 
2:2) suffering from an acute clinical outbreak of 
infectious bronchopneumonia
4 calves from different herds presented at the clinic with 
signs of infectious bronchopneumonia
Anamnesis
• 9 calves: 
Fever (>39,3°C), cough, nasal discharge,          
auscultation and ultrasound: pneumonia
4 calves presented at the clinic: no improvement with 





Columbia blood agar + PPLO broth
MALDI-TOF MS 
16S rRNA gene sequencing











• Identification: Gallibacterium anatis
MALDI-TOF MS: score >2.0
16S rRNA gene sequencing: 94-99% identification
6 pure cultures
1 dominant culture + Trueperella pyogenes
2 polybacterial cultures with G. anatis
No isolation Mycoplasma bovis
PCR: positive for 
Results
PI3 Corona
Histophilus somni Pasteurella multocida
• Susceptibility testing: 
Disk diffusion: Ceftiofur
MIC-gradient strip test: Amoxicillin-clavulanic-acid, 










Comparison with isolates from chickens
From: Jones et al., 2013
• 65% of the isolates are multidrug resistant
 Susceptibility against 4-9 antimicrobials
Especially sulfamethoxazole, tetracycline, tylosin, 
lincosamide, penicillin (El-Adawy, 2018; Bojesen, 2011; Jones, 2013)
• Isolates retrieved from calves:
100% multidrug resistant (minimum of 6 
antimicrobial classes)
Only susceptible for amoxicillin-clavulanic acid and 
ceftiofur
Comparison with isolates from chickens
Conclusion
• Gallibacterium anatis could play a role in 
infectious bronchopneumonia in calves
• Multiresistance is frequent in Gallibacterium 
anatis, potentially causing therapy failure
Discussion
• Gallibacterium anatis already described in cattle 
(joint, unknown origin: Christensen, 2003), first time 
associated with clinical outbreak
• Secondary pathogen causing pneumonia 
associated with viruses (f.e. Moraxella ovis, Catry, 2006)?
• No clinical breakpoints, interpretation 
susceptibility testing?
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